Intentional and unintentional non-adherence in community dwelling people with type 2 diabetes: The effect of varying numbers of medicines

British Journal of Diabetes and Vascular Disease

Volumn 10, Issue 3, 2010, Pages 148-152

  Stack, Rebecca J ^a   Bundy, Christine E ^b   Eliott, Rachel A ^c   New, John P ^d   Gibson, Martin ^d   Noyce, Peter R ^b  

^a UNIVERSITY OF SALFORD   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Adherence; Co morbid; Compliance; Decisionmaking; Polypharmacy

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; COMMUNITY LIVING; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; RATING SCALE; TREATMENT REFUSAL;

EID: 77957149613     PISSN: 14746514     EISSN: None     Source Type: Journal    
DOI: 10.1177/1474651409357034     Document Type: Article

References (23)

1. Mykkanen L, Kuusisto J, Pyorala K, Laakso M. Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 1993;36:553-9
2. Krentz A, Lawrence J, Summers L. Diabetes and Cardiovascular Disease. Oxford: Churchill Livingstone, 2005
3. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondia-betic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34
4. Booth GL, Kapral MK, Fung K, Tu JV. Recent trends in cardiovascular complications among men and women with and without diabetes Diabetes Care 2006;29:32-7
5. Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardio-vascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 2006;368:29-36
6. Beaglehole R, Yach D. Globalisation and the prevention and control of non-communicable disease: the neglected chronic diseases of adults Lancet 2003;362:903-08
7. Matthews DR, Pramming S. Diabetes and the global burden of non-communicable disease. Lancet 2003;362:1763-4
8. Bretzel RG, Voigt K, Schatz H. the United Kingdom Prospective Diabetes Study (UKPDS) implications for the pharmacotherapy of type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 1998;106: 369-72
9. Colhoun HM, Betteridge DJ, Durrington Pn et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre ran-domised placebo-controlled trial. Lancet 2004;364:685-96
10. Morris AD. the reality of type 2 diabetes treatment today Int J Clin Pract Suppl 2001;(121):32-5.
11. Rosenstock J. Management of type 2 diabetes mellitus in the elderly special considerations. Drugs Aging 2001;18:31-44
12. Paes AH, Bakker A, Soe-Agnie CJ. impact of dosage frequency on patient compliance. Diabetes Care 1997;20:1512-17
13. Donnan PT, MacDonald TM, Morris AD. Adherence to prescribed ora hypoglycaemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. Diabet Med 2002;19:279-84
14. Stack RJ, Elliott RA, Noyce PR, Bundy C. A qualitative exploration of multiple medicines beliefs in co-morbid diabetes and cardiovascular disease. Diabet Med 2008;25:1204-1210
15. World Health Organization. Adherence to Long-term therapies evidence for Action. Geneva: World Health Organization, 2003
16. Lutfey KE, Wishner WJ. beyond "compliance" is "adherence" impro-ving the prospect of diabetes care. Diabetes Care 1999;22:635-9
17. Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers application of the necessity-Concerns Framework. J Psychosom Res 2008;64:41-6
18. Branin JJ. the role of memory strategies in medication adherence among the elderly. Home Health Care Serv Q 2001;20:1-16
19. Pladevall M, Williams LK, Potts LA et al. Clinical outcomes and adher-ence to medications measured by claims data in patients with diabe-tes. Diabetes Care 2004;27:2800-05
20. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74
21. SPSS Inc. Statistical Package for the Social Sciences. Chicago: SPSS inc., 2007
22. Elliott RA, Ross-Degnan D, Adams AS, Safran DG, Soumerai SB Strategies for coping in a complex world: adherence among older adults with chronic illness. J Gen Intern Med 2007;22:805-10
23. Pound P Britten N, Morgan M et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med 2005;61 133-55